Seth J. Goldenberg
Impact in
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Oncology top 5%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 11
- Glycosylation and Glycoproteins Research 3
- Cancer-related gene regulation 3
- Wnt/β-catenin signaling in development and cancer 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Oncology 7
- Peptidase Inhibition and Analysis 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Ning Zheng (3 shared papers)Stéphane Angers (3 shared papers)Michael J. MacCoss (2 shared papers)Randall T. Moon (2 shared papers)Travis L. Biechele (2 shared papers)Benjamin Nicholson (7 shared papers)Craig A. Leach (5 shared papers)Michael R. Mattern (6 shared papers)
- Journals
- Biochemical Society Transactions (2 papers)Thrombosis Research (1 paper)Assay and Drug Development Technologies (1 paper)Cell (1 paper)Platelets (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Seth J. Goldenberg
16 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 1.5k
- Oncology 483
- Cell Biology 205
- Cancer Research 113
- Epidemiology 200
Countries citing papers authored by Seth J. Goldenberg
This map shows the geographic impact of Seth J. Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth J. Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth J. Goldenberg more than expected).
Fields of papers citing papers by Seth J. Goldenberg
This network shows the impact of papers produced by Seth J. Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth J. Goldenberg. The network helps show where Seth J. Goldenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth J. Goldenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 313 | |
| 2 | 2007 | 311 | |
| 3 | 2006 | 301 | |
| 4 | 2004 | 228 | |
| 5 | 2012 | 155 | |
| 6 | 2008 | 115 | |
| 7 | 2011 | 109 | |
| 8 | 2010 | 67 | |
| 9 | 2008 | 33 | |
| 10 | 2013 | 32 | |
| 11 | 2004 | 29 | |
| 12 | 2010 | 27 | |
| 13 | 2004 | 26 | |
| 14 | 2001 | 11 | |
| 15 | 2018 | 4 | |
| 16 | 2009 | 1 |
About Seth J. Goldenberg
Seth J. Goldenberg is a scholar working on Molecular Biology, Oncology, Hematology, Nephrology and Pharmacology, having authored 16 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (11 papers), Peptidase Inhibition and Analysis (5 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related gene regulation (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Protein Degradation and Inhibitors (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Oncology (483 citations), Cell Biology (205 citations), Cancer Research (113 citations) and Epidemiology (200 citations). Seth J. Goldenberg has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Ning Zheng, Stéphane Angers, Michael J. MacCoss, Randall T. Moon, Travis L. Biechele, Benjamin Nicholson, Craig A. Leach, Michael R. Mattern, Chris J. Thorpe and Yue Xiong. Their work appears in journals such as Biochemical Society Transactions, Thrombosis Research, Assay and Drug Development Technologies, Cell and Platelets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.